Cargando…
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study
microRNAs (miRNAs) have been proposed as promising molecular biomarkers for diagnosis, prognosis, and responsive therapeutic targets in different types of cancer, including colorectal cancer (CRC). In this study, we evaluated the expression levels of 84 cancer-associated miRNAs in a cohort of 39 hum...
Autores principales: | Milanesi, Elena, Dobre, Maria, Bucuroiu, Alina Ioana, Herlea, Vlad, Manuc, Teodora Ecaterina, Salvi, Alessandro, De Petro, Giuseppina, Manuc, Mircea, Becheanu, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330647/ https://www.ncbi.nlm.nih.gov/pubmed/32676506 http://dx.doi.org/10.1155/2020/4927120 |
Ejemplares similares
-
Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn's Disease and Ulcerative Colitis
por: Dobre, Maria, et al.
Publicado: (2018) -
Let-7 microRNAs Are Possibly Associated with Perineural Invasion in Colorectal Cancer by Targeting IGF Axis
por: Niculae, Andrei Marian, et al.
Publicado: (2022) -
Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patients
por: Milanesi, Elena, et al.
Publicado: (2019) -
Recent insights into the molecular pathogenesis of Crohn’s disease: a review of emerging therapeutic targets
por: Manuc, Teodora-Ecaterina M, et al.
Publicado: (2016) -
Molecular profile of the NF‐κB signalling pathway in human colorectal cancer
por: Dobre, Maria, et al.
Publicado: (2022)